Lexeo Therapeutics
LT
LE

Lexeo Therapeutics

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

2020Active91New York City, United States

About

Lexeo Therapeutics is a New York City-based, clinical-stage genetic medicine company focused on developing AAV-mediated treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer's disease. The company leverages pioneering science and a stepwise development approach to advance its pipeline of therapeutic candidates, aiming to address significant unmet medical needs.

Key facts

Website
lexeotx.com
Headquarters
New York City, United States
Founded
2020
Employees
91
Total funding
$495M (Public Offering)
Valuation
Private
Business model
B2B
Tags
Biotech
MedTech
HealthTech
Genomics
Drug Discovery

Funding rounds

Funding rounds raised by Lexeo Therapeutics
DateRoundAmountLead investors
16 Oct 2025Public Offering$135M-
27 May 2025Private Placement$80MFrazier Life Sciences, Janus Henderson Investors
11 Mar 2024Private Placement$95MAdage Capital Management
9 Sept 2021Series B$100MD1 Capital Partners
6 Jan 2021Series A$85MOmega Funds

Tech stack

Detected on lexeotx.com, last scanned 23 Sept 2026. Run your own scan

Frontend
jQuery
Analytics
Google Tag Manager
SEO
Yoast SEO
CMS / Builders
WordPress
Email provider
Microsoft 365
Cookie consent
Osano
Maps
Google Maps
Scores
Measured, not editorial
Ahrefs DR
41/100

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Agent Readiness
40/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Site Speed
72/100

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Add first review

Frequently asked

How much funding has Lexeo Therapeutics raised?

Lexeo Therapeutics has raised a total of $495M in funding. The most recent round on record is Public Offering.

How many employees does Lexeo Therapeutics have?

Lexeo Therapeutics has approximately 91 people on record.